FREQUENTLY ASKED QUESTIONS
-
No. Connura follows evidence-based remote monitoring protocols validated in multiple pregnancy trials. Patients use their own pregnancy-validated monitors and share data with you via PDF reports—similar to a paper log but with better technique reinforcement. As long as she's measuring correctly and sharing trends at appointments, this supports your care.
-
No. You remain the clinical decision-maker reviewing data she brings to appointments - the same workflow as if she kept a paper log. The app doesn't send real-time alerts that require an immediate response or create continuous monitoring obligations. Early research suggests structured home BP may reduce urgent visits and hospitalizations by improving early detection and patient technique.
-
Follow standard BP monitoring protocols:
Verify the at-home BP monitor is pregnancy-validated (not all devices are)
Have your patient bring the monitor to the office for a calibration check
Observe technique - positioning and cuff placement errors are common
Compare home readings to your baseline over several appointments
Adjust expectations or thresholds based on consistent variance
The app reinforces proper technique, but you can recalibrate clinical interpretation based on your assessment.
-
Connura provides technique guidance at the point of measurement: positioning reminders, timing protocols, and trimester-specific context. However, initial training from you or your staff remains essential. Have your patient demonstrate technique at the first visit, bring her at-home monitor for calibration, and review her app-generated reports to spot obvious technique issues.
-
That's your clinical judgment. Current evidence shows that at-home BP monitoring is safe in pregnancy and may improve outcomes when integrated into structured care. Many physicians mention it as an option for:
Patients with chronic hypertension or previous preeclampsia
High-risk patients who benefit from more frequent monitoring
Patients expressing anxiety about missing warning signs between visits
Postpartum monitoring to improve follow-up completion
Consider it a tool in your toolkit, not a requirement for all patients.
-
Not at this time. Patients share PDF reports with you directly via appointment, patient portal, or email. This keeps implementation simple and avoids workflow disruption while you evaluate whether home BP monitoring benefits your patient population.
EMR integration and provider-facing dashboards are planned for future releases, once patient adoption is established.
-
The app provides escalation guidance based on thresholds you established. For severe readings (≥160/110) or concerning symptoms that you can help establish in the App’s settings, the app directs your patient to contact your practice and can store your clinic's contact information. For high readings (>140/90), the app recommends remeasuring, contacting the clinic on the next business day, or sending a report for review.
NOTE - you define the “Severe” and” High” thresholds in the app and work with your patient to personalize her Connura App settings. The app is designed to follow your clinical protocol.
-
Connura is a Pregnancy-Specific Design:
Trimester-appropriate reference ranges (not generic adult thresholds)
Guidance for pregnancy physiology (positioning matters more, compression effects, gestational changes)
Postpartum continuity (when most apps stop, risk continues)
Clinical Partnership Model:
You establish thresholds and action plans.
Patient shares structured reports, not raw data streams.
Supports your decision-making rather than bypassing it
Evidence-Based Foundation:
Built on the research from pregnancy/postpartum BP monitoring trials
Follows ACOG measurement guidelines
Peer-reviewed outcomes showing safety and utility
Generic BP health apps treat pregnancy as another demographic. Connura is designed to help manage hypertensive disorders of pregnancy.